{"id":5680,"date":"2021-04-24T11:14:00","date_gmt":"2021-04-24T09:14:00","guid":{"rendered":"https:\/\/kedrion.lotrek.net\/?post_type=news&#038;p=5680"},"modified":"2021-05-24T11:15:03","modified_gmt":"2021-05-24T09:15:03","slug":"kedrion-kamada-anti-covid-ig-development-update","status":"publish","type":"news","link":"https:\/\/www.kedrion.it\/en\/kedrion-kamada-anti-covid-ig-development-update\/","title":{"rendered":"Kedrion-Kamada, Anti-COVID IG development update"},"content":{"rendered":"\n<p>Watch the interview given to LeFontiTV by the CEO of our partner Kamada<\/p>\n\n\n\n<!--more-->\n\n\n\n<p>Kedrion Biopharma and Kamada are forging ahead with the development of a new Anti-COVID Immunoglobulin therapy derived from the plasma of convalescent patients.<\/p>\n\n\n\n<p><strong><u><a href=\"https:\/\/www.lefonti.tv\/israeli-biotech-kamada-and-its-covid-19-treatment\/\">Watch today\u2019s interview by Kamada\u2019s CEO Amir London on <em>LeFontiTV<\/em> to learn more about the status of the project.<\/a><\/u><\/strong><\/p>\n","protected":false},"featured_media":0,"template":"","categories_news":[46],"class_list":["post-5680","news","type-news","status-publish","hentry","categories_news-plasma-biotherapies-en-us"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kedrion-Kamada, Anti-COVID IG development update - Kedrion Biopharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.kedrion.it\/en\/kedrion-kamada-anti-covid-ig-development-update\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kedrion-Kamada, Anti-COVID IG development update - Kedrion Biopharma\" \/>\n<meta property=\"og:description\" content=\"Watch the interview given to LeFontiTV by the CEO of our partner Kamada\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.kedrion.it\/en\/kedrion-kamada-anti-covid-ig-development-update\/\" \/>\n<meta property=\"og:site_name\" content=\"Kedrion Biopharma\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-24T09:15:03+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.kedrion.it\/en\/kedrion-kamada-anti-covid-ig-development-update\/\",\"url\":\"https:\/\/www.kedrion.it\/en\/kedrion-kamada-anti-covid-ig-development-update\/\",\"name\":\"Kedrion-Kamada, Anti-COVID IG development update - Kedrion Biopharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.kedrion.it\/#website\"},\"datePublished\":\"2021-04-24T09:14:00+00:00\",\"dateModified\":\"2021-05-24T09:15:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.kedrion.it\/en\/kedrion-kamada-anti-covid-ig-development-update\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.kedrion.it\/en\/kedrion-kamada-anti-covid-ig-development-update\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.kedrion.it\/en\/kedrion-kamada-anti-covid-ig-development-update\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.kedrion.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\/\/www.kedrion.it\/news-archive\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Kedrion-Kamada, Anti-COVID IG development update\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.kedrion.it\/#website\",\"url\":\"https:\/\/www.kedrion.it\/\",\"name\":\"Kedrion Biopharma\",\"description\":\"Plasma-Derived Medicinal Products | Keep Life Flowing\",\"publisher\":{\"@id\":\"https:\/\/www.kedrion.it\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.kedrion.it\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.kedrion.it\/#organization\",\"name\":\"Kedrion S.p.A.\",\"url\":\"https:\/\/www.kedrion.it\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.kedrion.it\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.kedrion.it\/wp-content\/uploads\/2021\/04\/Logo-Kedrion-yellow-1.jpg\",\"contentUrl\":\"https:\/\/www.kedrion.it\/wp-content\/uploads\/2021\/04\/Logo-Kedrion-yellow-1.jpg\",\"width\":1772,\"height\":870,\"caption\":\"Kedrion S.p.A.\"},\"image\":{\"@id\":\"https:\/\/www.kedrion.it\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kedrion-Kamada, Anti-COVID IG development update - Kedrion Biopharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.kedrion.it\/en\/kedrion-kamada-anti-covid-ig-development-update\/","og_locale":"en_US","og_type":"article","og_title":"Kedrion-Kamada, Anti-COVID IG development update - Kedrion Biopharma","og_description":"Watch the interview given to LeFontiTV by the CEO of our partner Kamada","og_url":"https:\/\/www.kedrion.it\/en\/kedrion-kamada-anti-covid-ig-development-update\/","og_site_name":"Kedrion Biopharma","article_modified_time":"2021-05-24T09:15:03+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.kedrion.it\/en\/kedrion-kamada-anti-covid-ig-development-update\/","url":"https:\/\/www.kedrion.it\/en\/kedrion-kamada-anti-covid-ig-development-update\/","name":"Kedrion-Kamada, Anti-COVID IG development update - Kedrion Biopharma","isPartOf":{"@id":"https:\/\/www.kedrion.it\/#website"},"datePublished":"2021-04-24T09:14:00+00:00","dateModified":"2021-05-24T09:15:03+00:00","breadcrumb":{"@id":"https:\/\/www.kedrion.it\/en\/kedrion-kamada-anti-covid-ig-development-update\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.kedrion.it\/en\/kedrion-kamada-anti-covid-ig-development-update\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.kedrion.it\/en\/kedrion-kamada-anti-covid-ig-development-update\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.kedrion.it\/en\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.kedrion.it\/news-archive\/"},{"@type":"ListItem","position":3,"name":"Kedrion-Kamada, Anti-COVID IG development update"}]},{"@type":"WebSite","@id":"https:\/\/www.kedrion.it\/#website","url":"https:\/\/www.kedrion.it\/","name":"Kedrion Biopharma","description":"Plasma-Derived Medicinal Products | Keep Life Flowing","publisher":{"@id":"https:\/\/www.kedrion.it\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.kedrion.it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.kedrion.it\/#organization","name":"Kedrion S.p.A.","url":"https:\/\/www.kedrion.it\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.kedrion.it\/#\/schema\/logo\/image\/","url":"https:\/\/www.kedrion.it\/wp-content\/uploads\/2021\/04\/Logo-Kedrion-yellow-1.jpg","contentUrl":"https:\/\/www.kedrion.it\/wp-content\/uploads\/2021\/04\/Logo-Kedrion-yellow-1.jpg","width":1772,"height":870,"caption":"Kedrion S.p.A."},"image":{"@id":"https:\/\/www.kedrion.it\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.kedrion.it\/en\/wp-json\/wp\/v2\/news\/5680","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.kedrion.it\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.kedrion.it\/en\/wp-json\/wp\/v2\/types\/news"}],"wp:attachment":[{"href":"https:\/\/www.kedrion.it\/en\/wp-json\/wp\/v2\/media?parent=5680"}],"wp:term":[{"taxonomy":"categories_news","embeddable":true,"href":"https:\/\/www.kedrion.it\/en\/wp-json\/wp\/v2\/categories_news?post=5680"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}